Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
John D. Matthews & Maurizio Fava. (2000) Risk of Suicidality in Depression with Serotonergic Antidepressants. Annals of Clinical Psychiatry 12:1, pages 43-50.
Read now
Read now
Articles from other publishers (24)
Michael J. Colwell, Hosana Tagomori, Sarah Chapman, Amy L. Gillespie, Philip J. Cowen, Catherine J. Harmer & Susannah E. Murphy. (2022) Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research. Translational Psychiatry 12:1.
Crossref
Crossref
Yakup Albayrak & Kenji Hashimoto. 2017. Sigma Receptors: Their Role in Disease and as Therapeutic Targets. Sigma Receptors: Their Role in Disease and as Therapeutic Targets
153
161
.
Ian Hindmarch & Kenji Hashimoto. (2010) Cognition and depression: the effects of fluvoxamine, a sigma‐1 receptor agonist, reconsidered. Human Psychopharmacology: Clinical and Experimental 25:3, pages 193-200.
Crossref
Crossref
Ichiro M Omori, Norio Watanabe, Atsuo Nakagawa, Andrea Cipriani, Corrado Barbui, Hugh McGuire, Rachel Churchill & Toshi A Furukawa. (2010) Fluvoxamine versus other anti-depressive agents for depression. Cochrane Database of Systematic Reviews.
Crossref
Crossref
George I. Papakostas, Per Bech & Maurizio Fava. 2009. Depressive Disorders. Depressive Disorders
47
74
.
George I. Papakostas, Michael E. Thase, Maurizio Fava, J. Craig Nelson & Richard C. Shelton. (2007) Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents. Biological Psychiatry 62:11, pages 1217-1227.
Crossref
Crossref
Corrado Barbui, Matthew Hotopf, Nick Freemantle, J Boynton, Rachel Churchill, Martin Eccles, John Geddes, Rebecca Hardy, Glyn Lewis & James Mason. (2006) Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). Cochrane Database of Systematic Reviews.
Crossref
Crossref
John Geddes, Nick Freemantle, James Mason, Martin Eccles & J Boynton. (2006) Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression. Cochrane Database of Systematic Reviews.
Crossref
Crossref
J. L. Carrasco & C. Sandner. (2005) Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview. International Journal of Clinical Practice 59:12, pages 1428-1434.
Crossref
Crossref
Andrew G. Mayers & David S. Baldwin. (2005) Antidepressants and their effect on sleep. Human Psychopharmacology: Clinical and Experimental 20:8, pages 533-559.
Crossref
Crossref
Emily Beth Devine, Zafar Hakim & Jesse Green. (2005) A Systematic Review of Patient-Reported Outcome Instruments Measuring Sleep Dysfunction in Adults. PharmacoEconomics 23:9, pages 889-912.
Crossref
Crossref
N. Zisapel & M. Laudon. (2003) Subjective assessment of the effects of CNS‐active drugs on sleep by the Leeds sleep evaluation questionnaire: a review. Human Psychopharmacology: Clinical and Experimental 18:1, pages 1-20.
Crossref
Crossref
G. Laux, A. Eckert, W. E. Müller, U. Breyer-Pfaff, S. Kasper, M. Riedel, N. Müller, H. J. Möller, C. Hiemke, C. Schöchlin & R. R. Engel. 2002. Neuro-Psychopharmaka Ein Therapie-Handbuch. Neuro-Psychopharmaka Ein Therapie-Handbuch
223
363
.
G. Laux, J. Fritze, W. König, O. Dietmaier & F. König. 2002. Neuro-Psychopharmaka Ein Therapie-Handbuch. Neuro-Psychopharmaka Ein Therapie-Handbuch
103
221
.
C Barbui, M Hotopf, N Freemantle, J Boynton, R Churchill, MP Eccles, JR Geddes, R Hardy, G Lewis & JM Mason. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
JR Geddes, N Freemantle, J Mason, MP Eccles & J Boynton. 1996. The Cochrane Database of Systematic Reviews. The Cochrane Database of Systematic Reviews.
Kevin M. Malone. (1997) PHARMACOTHERAPY OF AFFECTIVELY ILL SUICIDAL PATIENTS. Psychiatric Clinics of North America 20:3, pages 613-624.
Crossref
Crossref
Matthew Hotopf, Rebecca Hardy & Glyn Lewis. (2018) Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity. British Journal of Psychiatry 170:2, pages 120-127.
Crossref
Crossref
B. Gao & M.G. Cutler. (1994) Effects of acute and chronic administration of the antidepressants, imipramine, phenelzine and mianserin, on the social behaviour of mice. Neuropharmacology 33:6, pages 813-824.
Crossref
Crossref
M. Fux, M. Taub & J. Zohar. (1993) Emergence of depressive symptoms during treatment for panic disorder with specific 5-hydroxytryptophan reuptake inhibitors. Acta Psychiatrica Scandinavica 88:4, pages 235-237.
Crossref
Crossref
F Song, N Freemantle, T A Sheldon, A House, P Watson, A Long & J Mason. (1993) Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.. BMJ 306:6879, pages 683-687.
Crossref
Crossref
G. Laux, A. Delini-Stula, U. Breyer-Pfaff, J. Demling, D. Ebert, W. Pöldinger, S. Kasper, M. Osterheider, O. Dietmaier, H.-J. Möller & J. Fuger. 1993. Neuro-Psychopharmaka. Neuro-Psychopharmaka
105
268
.
A M Whitehead & J J Ashford. (1992) FLUVOXAMINE IN THE TREATMENT OF DEPRESSIVE ILLNESS. A SERIES OF DOUBLE‐BUND HOSPITAL BASED COMPARATIVE STUDIES CARRIED OUT IN THE UK. International Journal of Clinical Practice 46:1, pages 21-23.
Crossref
Crossref
C A L Moon & D K Jesinger. (1991) THE EFFECTS OF PSYCHOMOTOR PERFORMANCE OF FLUVOXAMINE VERSUS MIANSERIN IN DEPRESSED PATIENTS IN GENERAL PRACTICE. International Journal of Clinical Practice 45:4, pages 259-262.
Crossref
Crossref